Looking for cancer in the bloodstream – one patient at a time
Blood-based biomarkers offer a minimally invasive way to detect and monitor cancer. In the paper “Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls”, we explore whether cfRNA can capture cancer-related changes across the body.
